The closedown, and reopening
This is our final newsletter for 2023. Here’s the dates when we’ll be back in 2024 Our final newsletters for the year will be issued today (Thursday 21st): the final …
The top 25 stories of 2023
Weight loss, shortages, 60-day dispensing, CWH and more: which of our stories were the most read in 2023? There’s a usual pattern to the story themes that make our annual …
The top 10: Webinars
Continuing our review of our best read stories for 2023: the top 10 webinars The list does include some webinars from previous years which were also resonating with readers and …
The top 10: Opinion columns
Next up in our review of 2023: the 10 most read opinion columns for the year ‘I felt terrified but I will not allow such people to intimidate me’ Onsite …
The top 10: PDL practice alerts
Next in our review of 2023, the year’s ten most viewed alerts and advice for pharmacists from PDL Mounjaro update Practising ‘good’ dispensing Focusing on patient privacy Be alert but …
The top 10: work and the workplace
Our review of 2023 continues with a look at our 10 most read stories on issues around the pharmacy workplace and workforce $5000 to become the face of 60-day dispensing …
The top 10: business columns
Next in our review of 2023, our 10 best read business columns for the year Pharmacy’s ‘date that will live in infamy’ The 60-day disaster Aged care medications, who pays? …
“A bit of a kick in the teeth”
Changes are proposed to the structure of the Pharmacy Guild’s national council, and members from one state are unhappy with what may result Concerns have been raised over an impending …
The top 10: Features
We continue our review of 2023 by looking at our 10 best read longer form feature articles for the year Pharmacy Heroes: finding the heroes of pharmacy The crackdown on …
The top 10: AJP podcasts
We continue our review of the top stories of 2023 by looking at our 10 most popular podcasts of the year 60-day dispensing: the personal impact Running on adrenaline: hospital …
The top 10: CPD articles
We continue our review of 2023 with a look at the 10 most read CPD articles on our website this year Hypertension and antihypertensive drugs Red eyes vs dry eyes …